Alcon wins date with FDA panel for AcrySof lens

Alcon Laboratories wins a date with an FDA advisory panel to consider a new indication for its AcrySof IQ ReSTOR intraocular lens.

Alcon Laboratories won a date before an FDA advisory panel in November to review the data behind its application for a new indication for its AcrySof IQ ReSTOR intraocular lens, the watchdog agency said today.

The AcrySof IQ ReSTOR lens is already approved in the U.S. to treat presbyopia and cataracts.

Food & Drug Administration (FDA), Novartis AG, Alcon Inc.

News Well, Optical/Ophthalmic, Regulatory/Compliance

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1vlFyYz